We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Potential Molecular Biomarker Identified for Sepsis

By LabMedica International staff writers
Posted on 28 Oct 2013
A biomarker or biological footprint for sepsis that could form the basis of a rapid bedside blood test that returns results within two hours has been revealed. More...


Sepsis is a common cause of death in the intensive care unit with mortality up to 70% when accompanied by multiple organ dysfunction and therefore rapid diagnosis and the use of appropriate antibiotic therapy and pressor support are therefore critical for survival.

An international team of scientists collaborating with King's College London (London, UK) carried out a clinical study using blood taken from 23 sepsis patients and 22 systemic inflammatory response syndrome (SIRS) patients, together with 21 healthy volunteers. A validation cohort of 1,093 Swedish patients was recruited and a positive blood culture was found in 138 patients.

Massively parallel sequencing of micro ribonucleic acids (MiRNAs) was utilized for screening MiRNA candidates. Putative MiRNAs were validated using quantitative real-time PCR (qRT-PCR). MiRNA levels were detected by qRT-PCR using custom Locked Nucleic Acid (LNA) primers (Exiqon; Vedbaek, Denmark). A panel of known and novel MiRNAs was detectable in the blood of patients with sepsis. After qRT-PCR validation, MiRNA miR-150 and miR-4772-5p-iso were able to discriminate between patients who have systemic inflammatory response syndrome and patients with sepsis. This finding was also validated in the independent cohort with an average diagnostic accuracy of 86%.

Graham M. Lord, MA, MRCP, PhD, a professor of medicine and lead author of the study said, “Sepsis is a hidden killer, causing nearly a third of all hospital deaths. Rapid antibiotic treatment for the condition is vital as every minute counts. Yet current diagnostic methods can take up to two days, so an accurate diagnostic test that can be carried out at the patient's bedside is urgently needed. We have for the first time identified a group of biomarkers in the blood that are good indicators of sepsis. We have shown that it is possible to detect these markers by screening a patient's blood in the ward, a process which can deliver results within two hours." The study was published on October 16, 2013, in the journal Public Library of Science ONE.

King's College London
Exiqon 

Related Links:

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Repetitive Pipette
VWR® Stepper Pro
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A new study identifies distinct metabolomic signatures in maternal blood associated with both the timing and type of early birth (Image credit: iStock)

Maternal Blood Biomarkers Identify Risk of Preterm and Early-Term Birth

Preterm and early-term births can lead to lasting complications because vital organs continue to mature during the final weeks of pregnancy. Babies born too soon face increased risks of breathing difficulties,... Read more

Molecular Diagnostics

view channel
Image: The Fast PCR System delivers sample‑to‑answer results for key pathogens in under 10 minutes (Photo courtesy of Autonomous Medical Devices Incorporated)

Point-of-Care PCR Panel Detects RSV, Influenza, and SARS-CoV-2 in Minutes

Respiratory syncytial virus, influenza, and SARS-CoV-2 remain major respiratory pathogens in ambulatory care. RSV is a particular priority because it can cause significant disease in infants, older adults,... Read more

Industry

view channel
Image

QIAGEN Enhances QIAcuity Platform with Gene Expression and Multiplexing Tools

QIAGEN (Venlo, Netherlands) has introduced additions to its QIAcuity dPCR ecosystem that focus on gene expression, expanded assay content, and workflow standardization for life sciences and biopharma users.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.